India is amongst the top 12 preferred biotech destinations in the world
FDI through automatic route permitted for brownfield investments
producer of recombinant Hepatitis B vaccine.
developer of DNA Vaccine Against COVID-19
growth over the last decade
Supplier of DPT, Measles and BCG Vaccines
destination for clinical trials, contract research, and manufacturing.
USFDA approved pharma plants in India; 2nd largest outside of USA.
expected CAGR between 2022 and 2025
bio-incubators and 9 biotech parks, with new ones in the pipeline.
Recognizing the need for regulation of the use and application of Deoxyribonucleic Acid (DNA) technology in the country, “The DNA Technology (Use and Application) Regulation Bill - 2019”, has been formulated for establishing identity of missing persons, victims, offenders, under trials and unknown deceased persons.
+91-11-26511439, 26510068, 23386051
India has a well-oiled enterprise promoting machinery that is backed by strong legislative, judiciary, executive and capital establishments
Abbot Laboratories - American health care company
Sanofi Aventis - providers of diabetes drugs and vaccines
Endo Pharmaceuticals - Generics and speciality manufacturer
GE Healthcare - Medical equipment & diagnostic products
Bosch - Healthcare and medical technology manufacturer
Helix - Planning and design of healthcare facilities
BPI - IT solutions for business requirements in life sciences
Tekes - Financing research, development and innovation
India has a well-oiled enterprise promoting machinery that is backed by strong legislative, judiciary, executive, and capital establishments
The growth forecast for India’s FY24 real GDP was revised …Read More
India has recently signed a memorandum of understanding (MoU) with …Read More
The Atal Innovation Mission (AIM), NITI Aayog, and the US …Read More